Integral Diagnostics (ASX:IDX) FFO


ASX:IDX Integral Diagnostics Ltd ASX:IDX
73 GF Score
Price A$2.01
GF Value A$2.78
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Integral Diagnostics FFO?

FFO (Funds from operations) only applies to REITs.

ASX:IDX
73GF Score
Integral Diagnostics Ltd ASX:IDX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Integral Diagnostics (ASX:IDX) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued. The current stock price of A$2.01 is trading 27.7% below its estimated GF Value™ of A$2.78. GuruFocus considers Integral Diagnostics to be Modestly Undervalued.

Key valuation signals for ASX:IDX:

  • FFO:
  • GF Value™: A$2.78 vs. price of A$2.01 (27.7% below fair value)
  • GF Score™: 73/100 with 9 warning signs

No single metric tells the full story. See the ASX:IDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integral Diagnostics Business Description

Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
73GF Score

Get the complete analysis for ASX:IDX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.01
Price
A$2.78
GF Value